Adjuvant endocrine therapy for premenopausal women with breast cancer. - Wikidata - awgldk - TriplyDB

Adjuvant endocrine therapy for premenopausal women with breast cancer.

Adjuvant endocrine therapy for premenopausal women with breast cancer.

http://www.wikidata.org/entity/Q37515404

about

Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer.Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women.Management of patients with metastatic breast cancer.Physical activity and body composition, body physique, and quality of life in premenopausal breast cancer patients during endocrine therapy--a feasibility study.Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.

P2860

Q26783705-BEB8F0EB-D654-44F3-A7CA-2143A800B33A Q34303205-7267B4E7-DBD8-4D9C-9FBD-AC2AC3AACFA0 Q35617340-213CC1C5-CE8B-4FC9-A0AD-2EEDB528DE05 Q35920776-6AEF85EF-02C7-4CD2-A9E9-C32432757A20 Q37690054-F13022F2-D335-4286-B207-5AB5A4E10709 Q37933166-57CDAC9D-928F-4684-B7BE-15ABB476EC2E Q43493964-B9A77929-237F-4ECA-83BF-B584B028EA11 Q47110708-9C1C0611-70F2-4F65-87C6-9FF30BEBE96E

P2860

Adjuvant endocrine therapy for premenopausal women with breast cancer.

http://www.wikidata.org/entity/Q37515404

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adjuvant endocrine therapy for premenopausal women with breast cancer.

@en

Adjuvant endocrine therapy for premenopausal women with breast cancer.

@nl

type

label

Adjuvant endocrine therapy for premenopausal women with breast cancer.

@en

Adjuvant endocrine therapy for premenopausal women with breast cancer.

@nl

prefLabel

Adjuvant endocrine therapy for premenopausal women with breast cancer.

@en

Adjuvant endocrine therapy for premenopausal women with breast cancer.

@nl

P1433

Q37515404-13490FB1-5CE6-4801-BA27-8D5AE4B87EAF

P1476

Q37515404-D0B40C1A-755B-4BF2-9C4C-3DD7A57CC5E0

P2093

Q37515404-0EC5407F-0477-4581-9979-24CF77AE92A9

Q37515404-4644FF85-D1F0-401C-9E04-18008092F655

Q37515404-9C753987-15D3-48A7-99D3-541F53EF7011

P2860

Q37515404-010F95DD-E2D4-417C-BB27-38D4645353BA

Q37515404-044A5B83-A9D0-42BA-AD68-EF9990F56165

Q37515404-0ACC1880-29CD-4D4F-95E6-2EC9E19AC954

Q37515404-11E7C762-3A89-41B7-A9E0-2B0A6484D25F

Q37515404-187247FC-6306-4548-BDCE-CA26AD437BCC

Q37515404-3687B8F8-B294-40D6-A747-40FECA42D36A

Q37515404-3CA6A03E-4F1E-4D6C-9FDD-1372D8B23D9E

Q37515404-3E582D13-D005-4F94-92AF-4E700513940F

Q37515404-413D7FEB-3F90-40CC-8915-7C50EE43179E

Q37515404-46618440-0B67-4783-95D2-D482F5AEC6C9

P304

Q37515404-62104BA8-DBBC-497B-AFC6-BC91E565EC25

P31

Q37515404-1822AA4B-6515-4107-8E75-E79925AF60EA

P356

Q37515404-41D04BD9-EB04-4ED6-92DB-CBF765B33481

P478

Q37515404-6AD0B27D-7719-4BEC-B0B8-12E6E6A4A199

P577

Q37515404-73841C38-7C8F-4E2F-979C-1FA38CB56894

P698

Q37515404-A51C2921-261F-4E6B-8E67-2DB393BEA90D

P932

Q37515404-CCDB5D60-2A72-47BE-BCA0-599CF7F0FA4D

P356

S0960-9776(09)70286-3

P1433

P1476

Adjuvant endocrine therapy for premenopausal women with breast cancer.

@en

P2093

Adam Brufsky

http://www.w3.org/2001/XMLSchema#string

Nancy Davidson

http://www.w3.org/2001/XMLSchema#string

Shannon Puhalla

http://www.w3.org/2001/XMLSchema#string

P2860

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.

Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review.

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action.

P304

S122-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0960-9776(09)70286-3

http://www.w3.org/2001/XMLSchema#string

P478

18 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19914530

http://www.w3.org/2001/XMLSchema#string

P932

3901991

http://www.w3.org/2001/XMLSchema#string